SUMMARY
# Experiment Validation: In vitro ThT Assay
## Background and Rationale
The validation of computational models through experimental verification represents a critical juncture in contemporary neuroscience research, particularly in the study of protein aggregation disorders such as Alzheimer's disease. This in vitro Thioflavin-T (ThT) fluorescence assay serves as an essential bridge between sophisticated multiscale computational predictions and empirical reality, addressing one of the most pressi
METHODOLOGY NOTES
**Phase 1: Sample Preparation and Protein Purification (Days 1-3)**
• Express and purify recombinant amyloid-β peptides (Aβ40 and Aβ42) using established protocols
• Prepare monomeric peptide solutions in HFIP (1,1,1,3,3,3-hexafluoro-2-propanol) at 1 mg/mL
• Lyophilize and store at -80°C until use
• Prepare working solutions in PBS (pH 7.4) at concentrations: 10, 25, 50, 100 μM
• Filter through 0.22 μm filters to remove pre-formed aggregates
• Validate monomer purity using size exclusion chromatography and mass spectrometry
**Phase 2: ThT Assay Setup and Kinetic Measurements (Days 4-11)**
• Prepare ThT stock solution (1 mM in distilled water, filter sterilized)
• Set up 384-well black plates with final concentrations: 20 μM ThT, peptide concentrations as above
• Include controls: ThT alone, peptide alone, pre-formed fibril standards
• Perform measurements in triplicate for each condition (n=24 wells per concentration)
• Monitor fluorescence kinetics (λex=440 nm, λem=480 nm) every 10 m